Industry Insights
Real-Time Wastewater Monitoring Enables Rapid COVID-19 Outbreak Detection
Industry InsightWe spoke to Ari Goldfarb, CEO of Kando, about how their wastewater monitoring technology works and how it is being applied to the current monitoring efforts in the COVID-19 pandemic.
Read More
Blood Test Detects Over 50 Different Cancers With a 0.7% False-Positive Rate
Industry InsightEarlier this year, researchers reported in Annals of Oncology that they had developed a blood test that was able to detect, with 99.3% specificity, more than 50 types of cancer and identify exactly where in the body the cancer had originated – in some cases before any symptoms of the disease had manifested. We spoke to the study’s corresponding author, Michael V. Seiden MD PhD, to learn more.
Read More
Measuring the T Cell Immune Response to COVID-19
Industry InsightTo discover how the strength of a person’s immune response to SARS-CoV-2 can be assessed, and why this is important, Technology Networks spoke with Andrew Makin, VP Medical Affairs, Oxford Immunotec.
Read More
Driving Speed, Sensitivity and Precision in Modern Proteomics
Industry InsightTechnology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.
Read More
Cryo-EM Advances Are Good News for Drug Discovery
Industry InsightExciting recent developments are seeing cryo-EM compete with other structural biology techniques for resolution. We spoke to Raymond Schrijver from Thermo Fisher Scientific, about why cryo-EM is so important to drug discovery and ways in which the technique is becoming more accessible.
Read More
Optimizing the Discovery of Synthetic Antibodies for SARS-CoV-2
Industry InsightWhen the COVID-19 global pandemic was declared in March, Twist Biopharma decided to utilize its synthetic antibody discovery libraries to discover antibodies that could have diagnostic or treatment capabilities. Technology Networks spoke with Aaron Sato, Chief Scientific Officer, Twist Biopharma, to find out more.
Read More
From Genome Engineering to COVID-19 Diagnostic Testing at IGI
Industry InsightThe Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.
Read More
Asset Monitoring in the Life Sciences: Do Labs Need To Keep a Closer Eye on Their Instruments?
Industry InsightIn the day-to-day of research science, the acquisition of a new piece of equipment is a momentous occasion, but one that could see costs and inefficiencies spiral unless labs keep a close eye on their new kit. Asset monitoring software could lend a hand. We spoke to Agilent's Marc Boreham to find out more.
Read More
13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
Industry InsightThe World Health Organization recognizes that, as of June 22, there are over 140 vaccines against COVID-19 in various stages of development. 13 of those candidates are now in human clinical trials. In this insights piece, we explore what those candidates are, and who is developing them.
Read More
Moving Ions Around Corners To Revolutionize Disease Detection and Biotherapeutic Development
Industry InsightThe study of proteins, lipids, metabolites and other related molecules are invaluable in early disease detection and biotherapeutic development. An innovative separation technology borne out of a US Federal Laboratory, known as structures for lossless ion manipulation, is helping scientists to achieving this.
Read More
